Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.

MLA

Cideciyan, Artur V., et al. “Human Gene Therapy for RPE65 Isomerase Deficiency Activates the Retinoid Cycle of Vision but with Slow Rod Kinetics.” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 39, Sept. 2008, pp. 15112–17. EBSCOhost, https://doi.org/10.1073/pnas.0807027105.

APA

Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Ji-jing Pang, Sumaroka, A., Windsor, E. A. M., Wilson, J. M., Flotte, T. R., Fishman, G. A., Heon, E., Stone, E. M., Byrne, B. J., Jacobson, S. G., & Hauswirth, W. W. (2008). Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proceedings of the National Academy of Sciences of the United States of America, 105(39), 15112–15117. https://doi.org/10.1073/pnas.0807027105

Chicago

Cideciyan, Artur V., Tomas S. Aleman, Sanford L. Boye, Sharon B. Schwartz, Shalesh Kaushal, Alejandro J. Roman, Ji-jing Pang, et al. 2008. “Human Gene Therapy for RPE65 Isomerase Deficiency Activates the Retinoid Cycle of Vision but with Slow Rod Kinetics.” Proceedings of the National Academy of Sciences of the United States of America 105 (39): 15112–17. doi:10.1073/pnas.0807027105.